JP2018536427A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018536427A5 JP2018536427A5 JP2018530515A JP2018530515A JP2018536427A5 JP 2018536427 A5 JP2018536427 A5 JP 2018536427A5 JP 2018530515 A JP2018530515 A JP 2018530515A JP 2018530515 A JP2018530515 A JP 2018530515A JP 2018536427 A5 JP2018536427 A5 JP 2018536427A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- strain
- composition
- formulation according
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 46
- 238000009472 formulation Methods 0.000 claims description 31
- 208000008589 Obesity Diseases 0.000 claims description 8
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims description 8
- 235000020824 obesity Nutrition 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 6
- 235000013336 milk Nutrition 0.000 claims description 6
- 239000008267 milk Substances 0.000 claims description 6
- 210000004080 milk Anatomy 0.000 claims description 6
- 241001608472 Bifidobacterium longum Species 0.000 claims description 5
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 5
- 208000001145 Metabolic Syndrome Diseases 0.000 claims description 4
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 235000018102 proteins Nutrition 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 235000013618 yogurt Nutrition 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 235000014633 carbohydrates Nutrition 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 235000013351 cheese Nutrition 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000013270 controlled release Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 235000013406 prebiotics Nutrition 0.000 claims description 2
- 239000006041 probiotic Substances 0.000 claims description 2
- 230000000529 probiotic effect Effects 0.000 claims description 2
- 235000018291 probiotics Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000011573 trace mineral Substances 0.000 claims description 2
- 235000013619 trace mineral Nutrition 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 239000011707 mineral Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 3
- 239000002366 mineral element Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15199660 | 2015-12-11 | ||
| EP15199660.0 | 2015-12-11 | ||
| PCT/EP2016/080454 WO2017097987A1 (en) | 2015-12-11 | 2016-12-09 | Bifidobacterium longum for treating obesity and associated metabolic disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018536427A JP2018536427A (ja) | 2018-12-13 |
| JP2018536427A5 true JP2018536427A5 (enExample) | 2020-01-09 |
| JP6843140B2 JP6843140B2 (ja) | 2021-03-17 |
Family
ID=55070675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018530515A Active JP6843140B2 (ja) | 2015-12-11 | 2016-12-09 | 肥満および関連する代謝障害を処置するためのビフィドバクテリウム・ロングム |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10973862B2 (enExample) |
| EP (1) | EP3386523B1 (enExample) |
| JP (1) | JP6843140B2 (enExample) |
| KR (1) | KR102819885B1 (enExample) |
| CN (1) | CN109069552B (enExample) |
| AU (1) | AU2016368527B2 (enExample) |
| BR (1) | BR112018011665A2 (enExample) |
| CA (1) | CA3006176C (enExample) |
| DK (1) | DK3386523T3 (enExample) |
| ES (1) | ES2760076T3 (enExample) |
| MX (1) | MX378890B (enExample) |
| PL (1) | PL3386523T3 (enExample) |
| RU (1) | RU2740096C2 (enExample) |
| WO (1) | WO2017097987A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016070151A1 (en) | 2014-10-31 | 2016-05-06 | Whole Biome. Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| CN110392734A (zh) | 2017-02-28 | 2019-10-29 | 营养健康有限公司 | 可以有益地调节针对呼吸道病毒感染的免疫应答的长双歧杆菌 |
| EP3673044A1 (en) | 2017-08-25 | 2020-07-01 | University College Cork-National University of Ireland, Cork | Bifidobacterium longum for treating obesity and weight management |
| JP2020532515A (ja) | 2017-08-30 | 2020-11-12 | ペンデュラム セラピューティクス， インコーポレイテッド | マイクロバイオーム関連障害の処置のための方法および組成物 |
| CN117701424A (zh) * | 2018-04-11 | 2024-03-15 | 韩国生命工学研究院 | 具有肥胖预防或治疗效果的新的鼠李糖乳杆菌菌株及其用途 |
| CN113164526A (zh) | 2018-07-19 | 2021-07-23 | 潘德勒姆治疗公司 | 用于微生物植入的方法和组合物 |
| KR102224072B1 (ko) * | 2019-08-19 | 2021-03-10 | 주식회사 빙그레 | 면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도 |
| WO2021180973A1 (en) | 2020-03-13 | 2021-09-16 | Precisionbiotics Group Limited | Bifidobacterium longum |
| CN113564069B (zh) * | 2021-05-28 | 2023-09-29 | 中山大学 | 一种长双歧杆菌、长双歧杆菌胞外多糖及其提取方法和应用 |
| CN115466689B (zh) * | 2022-02-09 | 2023-06-16 | 中国科学技术大学 | 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用 |
| BG67720B1 (bg) * | 2022-03-18 | 2025-04-30 | "Ел Би Булгарикум" ЕАД | Щам bifidobacterium longum ssp. longum и бифидобактериален препарат с хиполипидемичен ефект, противовъзпалителен имуномодулиращ ефект и с намаляващ инсулиновата резистентност ефект |
| CN115637237B (zh) * | 2022-09-07 | 2024-09-17 | 辽宁贝克瑞生物科技有限公司 | 一株长双歧杆菌及其应用 |
| KR102789455B1 (ko) * | 2025-02-05 | 2025-04-04 | 주식회사 리스큐어바이오사이언시스 | 체지방 저감, 혈당 개선 및 근육 기능 강화 활성이 우수한 비피도박테리움 롱검 아종 롱검 lbmb322020 균주 및 이를 포함하는 대사성 질환 예방, 개선 또는 치료용 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1974734A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
| US8557233B2 (en) | 2007-03-28 | 2013-10-15 | Alimentary Heath Limited | Probiotic bifidobacterium strains |
| JP2010526055A (ja) * | 2007-05-04 | 2010-07-29 | アリメンタリー・ヘルス・リミテッド | エキソ多糖 |
| ES2566496T3 (es) * | 2008-11-11 | 2016-04-13 | Alimentary Health Limited | Bifidobacterium longum |
| EP2308499A1 (en) * | 2009-09-30 | 2011-04-13 | Nestec S.A. | Bifidobacterium longum ATCC BAA-999 (BL999) and weight control |
| CA2779418C (en) * | 2009-11-11 | 2018-03-20 | Alimentary Health Limited | Probiotic bifidobacterium strain |
| CA3092318A1 (en) * | 2012-09-20 | 2014-03-27 | Prothera, Inc. | Probiotic compositions and methods for the treatment of obesity and obesity-related conditions |
-
2016
- 2016-12-09 KR KR1020187016182A patent/KR102819885B1/ko active Active
- 2016-12-09 WO PCT/EP2016/080454 patent/WO2017097987A1/en not_active Ceased
- 2016-12-09 US US16/060,765 patent/US10973862B2/en active Active
- 2016-12-09 MX MX2018006905A patent/MX378890B/es unknown
- 2016-12-09 CN CN201680079991.4A patent/CN109069552B/zh active Active
- 2016-12-09 JP JP2018530515A patent/JP6843140B2/ja active Active
- 2016-12-09 BR BR112018011665A patent/BR112018011665A2/pt not_active Application Discontinuation
- 2016-12-09 EP EP16820183.8A patent/EP3386523B1/en active Active
- 2016-12-09 ES ES16820183T patent/ES2760076T3/es active Active
- 2016-12-09 RU RU2018119287A patent/RU2740096C2/ru active
- 2016-12-09 DK DK16820183.8T patent/DK3386523T3/da active
- 2016-12-09 CA CA3006176A patent/CA3006176C/en active Active
- 2016-12-09 AU AU2016368527A patent/AU2016368527B2/en active Active
- 2016-12-09 PL PL16820183T patent/PL3386523T3/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018536427A5 (enExample) | ||
| RU2018119287A (ru) | Бифидобактерии лонгум для лечения ожирения и связанных с ним метаболических нарушений | |
| Trush et al. | The evolution of human probiotics: challenges and prospects | |
| Shigwedha | Probiotical cell fragments (PCFs) as “novel nutraceutical ingredients” | |
| ES2764785T3 (es) | Bacteroides cect 7771 y su uso en la prevención y tratamiento de sobrepeso, obesidad y alteraciones metabólicas e inmunológicas | |
| AU2009264417B2 (en) | Probiotics, secretory IgA and inflammation | |
| JP2014505065A5 (enExample) | ||
| AU2015100952A4 (en) | Probiotic- and enzyme-containing compositions and uses thereof | |
| HRP20161792T1 (hr) | Sojevi bifidobacterium bifiduma za primjenu u gastrointestinalnim bolestima | |
| KR102825170B1 (ko) | 프로바이오틱 비피도박테리움 브레베 균주 및 상기 균주를 포함하는 조성물 | |
| JP2014505467A (ja) | ビフィドバクテリウム属ｃｅｃｔ７７６５および過体重、肥満および関連病変の予防および／または治療におけるその使用 | |
| Khan et al. | Gut microbiota and probiotics: current status and their role in cancer therapeutics | |
| ES2763350B2 (es) | Cepa de christensenella minuta y uso de la misma | |
| Cai et al. | Surface-displayed IL-10 by recombinant Lactobacillus plantarum reduces Th1 responses of RAW264. 7 cells stimulated with poly (I: C) or LPS | |
| WO2016148562A1 (en) | Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic | |
| CN102647991B (zh) | 抗病毒剂和饮食品组合物 | |
| JP2024098008A (ja) | 免疫チェックポイント阻害療法を促進するための組成物 | |
| Abdul Kalam Saleena et al. | A comprehensive review of Bifidobacterium spp: as a probiotic, application in the food and therapeutic, and forthcoming trends | |
| Zhang et al. | Anti-breast cancer effects of dairy protein active peptides, dairy products, and dairy protein-based nanoparticles | |
| Ashaolu et al. | Action and immunomodulatory mechanisms, formulations, and safety concerns of probiotics | |
| JP6916042B2 (ja) | 抗原特異的インターフェロンγ産生促進用組成物 | |
| Attri et al. | Probiotics and their potential applications: an introduction | |
| JP5209294B2 (ja) | インターロイキン１２産生促進剤 | |
| TW201138651A (en) | Agent for controlling the increase and decrease of lactobacillus bifidus in colon | |
| Fröhlich et al. | Reevaluating the hype: four bacterial metabolites under scrutiny |